共 50 条
- [1] Orlistat improves on the features of metabolic syndrome in obese patients with type 2 diabetesOBESITY RESEARCH, 2004, 12 : A39 - A39Kim, YSPark, CYSon, HYLee, HC
- [2] Improvement of glycemic control with orlistat in overweight and obese patients with metabolic syndrome and type 2 diabetesDIABETES, 2003, 52 : A557 - A557Hollander, PRissanen, ARabbia, MHauptman, JBoldrin, M
- [3] Orlistat improves all components of the metabolic syndrome in overweight and obese patients on two dietsINTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S154 - S154Jacob, SZiegler, OToplak, H
- [4] Efficacy of orlistat in overweight or obese patients with type 2 diabetes in SwedenDIABETES, 2003, 52 : A556 - A556Berne, C
- [5] Orlistat enhances weight loss and improves cardiovascular risk factors in overweight and obese patients with Type 2 diabetesDIABETOLOGIA, 2004, 47 : A250 - A250Guy-Grand, BCaterson, ILindgärde, FShi, YEBroom, L
- [6] The ORListat and cardiovascular risk profile in patients with metabolic syndrome and type 2 Diabetes (ORLICARDIA) studyCURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1393 - 1401Didangelos, TPThanopoulou, AKBousboulas, SHSambanis, CLAthyros, VGSpanou, EADimitriou, KCPappas, SIKaramanos, BGKaramitsos, DT
- [7] Orlistat consistently improves glycemic control in patients with type 2 diabetesDIABETES, 2002, 51 : A472 - A472Hollander, PAVan Gaal, L
- [8] Effect of orlistat in overweight and obese type 2 diabetes patients treated with metforminDIABETOLOGIA, 2001, 44 : A231 - A231Miles, JAronne, LHollander, PKlein, S
- [9] Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitusPHARMACOECONOMICS, 2003, 21 (07) : 501 - 512Maetzel, ARouf, JCovington, MWolf, A
- [10] Haemostatic and fibrinolytic abnormalities in obese patients and in patients with type 2 diabetes with metabolic syndromeATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 420 - 420Avellone, G.Di Garbo, V.Scaglione, R.Fernandez, P.De Simone, R.Raneli, G.Licata, G.